We are live on
!
Find out more
HCA
Horan Capital Advisors Portfolio holdings
AUM
$297M
1-Year Est. Return
9.75%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+9.75%
3 Year Est. Return
+26.64%
5 Year Est. Return
+133.08%
10 Year Est. Return
+209.33%
AUM
$98M
AUM Growth
+$13.9M
(+17%)
Cap. Flow
+$4.14M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
78
New
16
Increased
44
Reduced
9
Closed
6
Avg Time Held
1.4
quarters
Top 10 Avg Time Held
1.4
quarters
Top 20 Avg Time Held
1.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSMA
CREDIT SUISSE X-LINKS MERGER ARBITRAGE ETNS DUE 10/6/2020
CSMA
|
+$4.26M |
| 2 |
American Express
AXP
|
+$1.82M |
| 3 |
Macy's
M
|
+$1.3M |
| 4 |
PDM
Piedmont Realty Trust
PDM
|
+$980K |
| 5 |
Realty Income
O
|
+$938K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLPN
Credit Suisse X- Links Cushing MLP Infrastructure ETN's due April 20, 2020
MLPN
|
+$5.68M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$1.65M |
| 3 |
FirstEnergy
FE
|
+$1.18M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$415K |
| 5 |
WesBanco
WSBC
|
+$328K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.32% |
| 2 | Healthcare | 12.69% |
| 3 | Industrials | 11.34% |
| 4 | Financials | 11.25% |
| 5 | Technology | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DD
26
DELISTED
Du Pont De Nemours E I
DD
| $1.51M | 1.54% |
24,522
+1,006
| +4% | +$58.1K |
2013 Q2
2 quarters
|
|
27
DuPont de Nemours
DD
$17.6B
| $1.51M | 1.54% |
13,416
+916
| +7% | +$93.9K |
2013 Q3
1 quarter
|
|
28
Cinemark Holdings
CNK
$4.17B
| $1.47M | 1.5% |
44,222
+1,335
| +3% | +$43.8K |
2013 Q2
2 quarters
|
|
29
Novartis
NVS
$268B
| $1.44M | 1.47% |
20,020
+1,049
| +6% | +$72.9K |
2013 Q2
2 quarters
|
|
30
Lazard
LAZ
$3.44B
| $1.44M | 1.47% |
31,796
+786
| +3% | +$31.8K |
2013 Q2
2 quarters
|
|
|
31
Macy's
M
$5.88B
| $1.44M | 1.46% |
+26,875
| New | +$1.3M |
2013 Q4
0 quarters
|
|
32
Thomson Reuters
TRI
$42.1B
| $1.42M | 1.45% |
32,348
-6,463
| -17% | -$276K |
2013 Q2
2 quarters
|
|
|
RDS.A
33
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.42M | 1.44% |
21,261
+873
| +4% | +$54.8K |
2013 Q2
2 quarters
|
|
34
Thermo Fisher Scientific
TMO
$250B
| $1.39M | 1.42% |
12,455
-60
| -0.5% | -$5.97K |
2013 Q2
2 quarters
|
|
35
AbbVie
ABBV
$470B
| $1.34M | 1.37% |
25,459
+3,637
| +17% | +$179K |
2013 Q2
2 quarters
|
|
36
Comcast
CMCSA
$76.5B
| $1.32M | 1.34% |
50,692
+1,274
| +3% | +$30.7K |
2013 Q2
2 quarters
|
|
37
Johnson & Johnson
JNJ
$610B
| $1.24M | 1.26% |
13,508
+445
| +3% | +$41K |
2013 Q2
2 quarters
|
|
38
Pfizer
PFE
$156B
| $1.1M | 1.12% |
37,814
+1,199
| +3% | +$34.9K |
2013 Q2
2 quarters
|
|
39
Abbott
ABT
$173B
| $1.06M | 1.08% |
27,544
+11,267
| +69% | +$415K |
2013 Q2
2 quarters
|
|
40
Clean Harbors
CLH
$17B
| $965K | 0.98% |
16,095
+1,205
| +8% | +$69.5K |
2013 Q3
1 quarter
|
|
41
Mondelez International
MDLZ
$74.7B
| $958K | 0.98% |
27,144
+595
| +2% | +$19.8K |
2013 Q2
2 quarters
|
|
|
PDM
42
Piedmont Realty Trust
PDM
$1.12B
| $936K | 0.96% |
+56,650
| New | +$980K |
2013 Q4
0 quarters
|
|
43
Accenture
ACN
$119B
| $916K | 0.93% |
11,136
+2,165
| +24% | +$164K |
2013 Q2
2 quarters
|
|
|
MON
44
DELISTED
Monsanto Co
MON
| $916K | 0.93% |
+7,858
| New | +$858K |
2013 Q4
0 quarters
|
|
45
Automatic Data Processing
ADP
$103B
| $892K | 0.91% |
12,569
+222
| +2% | +$14.9K |
2013 Q2
2 quarters
|
|
|
46
Realty Income
O
$50.9B
| $884K | 0.9% |
+24,427
| New | +$938K |
2013 Q4
0 quarters
|
|
47
Vanguard FTSE Emerging Markets ETF
VWO
$128B
| $673K | 0.69% |
16,363
-4,510
| -22% | -$186K |
2013 Q2
2 quarters
|
|
48
Microsoft
MSFT
$3.9T
| $650K | 0.66% |
17,369
-389
| -2% | -$14.1K |
2013 Q3
1 quarter
|
|
49
IBM
IBM
$209B
| $638K | 0.65% |
3,557
+123
| +4% | +$21.2K |
2013 Q2
2 quarters
|
|
50
Biogen
BIIB
$33B
| $607K | 0.62% |
2,171
+154
| +8% | +$39.8K |
2013 Q3
1 quarter
|
|
Similar funds
WGCA
RAM
WFA
PPWP
RI
BCM
IAM
UFA
Horan Capital Advisors's Q4 2013 Portfolio in Review
As of Q4 2013, Horan Capital Advisors held 78 positions worth $98M, up 17% from $84.1M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Horan Capital Advisors deployed $4.14M of net new capital in Q4 2013, opening 16 new positions and adding to 44 existing holdings. Its largest new stake was CREDIT SUISSE X-LINKS MERGER ARBITRAGE ETNS DUE 10/6/2020: 203,329 shares worth $6.39M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was WesBanco, an estimated $328K trimmed.
- Horan Capital Advisors's largest Q4 2013 buy was CREDIT SUISSE X-LINKS MERGER ARBITRAGE ETNS DUE 10/6/2020: 203,329 shares worth $6.39M.
- Horan Capital Advisors added most to Abbott in Q4 2013, an estimated $415K increase.
- Horan Capital Advisors's biggest Q4 2013 reduction was WesBanco, cutting an estimated $328K.
- Horan Capital Advisors fully exited Credit Suisse X- Links Cushing MLP Infrastructure ETN's due April 20, 2020 in Q4 2013, selling an estimated $5.68M.
- Horan Capital Advisors's ten largest holdings make up 39% of its $98M portfolio in Q4 2013.
- Horan Capital Advisors opened 16 new positions and closed 6 in Q4 2013.
- Horan Capital Advisors's portfolio value rose 17% quarter-over-quarter to $98M.
Based on Horan Capital Advisors's 13F filing for Q4 2013, filed 21 Jan 2014.